Impact of the International Consensus Classification of myelodysplastic syndromes

被引:7
|
作者
Zhang, Yudi [1 ]
Wu, Junying [1 ]
Xu, Zefeng [1 ,2 ]
Qin, Tiejun [2 ]
Qu, Shiqiang [1 ,2 ]
Pan, Lijuan [2 ]
Wang, Huijun [3 ]
Sun, Qi [3 ]
Li, Chengwen [3 ]
Jia, Yujiao [3 ]
Cai, Wenyu [3 ]
Yan, Xin [1 ]
Gong, Jingye [1 ]
Gao, Qingyan [1 ,2 ]
Li, Bing [1 ,2 ]
Gale, Robert Peter [4 ]
Xiao, Zhijian [1 ,2 ,3 ,5 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Haihe Lab Cell Ecosyst,Inst Hematol & Blood Dis Ho, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, MDS & MPN Ctr, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Hematol Pathol Ctr, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China
[4] Imperial Coll London, Haematol Res Ctr, Dept Immunol & Inflammat, London, England
[5] Chinese Acad Med Sci & Peking Union Med Coll, MDS & MPN Ctr, Inst Hematol & Blood Dis Hosp, 288 Nanjing Rd, Tianjin 300020, Peoples R China
基金
中国国家自然科学基金;
关键词
International Consensus Classification; myelodysplastic syndromes; prognostic; World Health Organization classification; SUBGROUP; OUTCOMES; BLASTS; MDS;
D O I
10.1111/bjh.18628
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The impact of the 2022 International Consensus Classification (ICC) of myelodysplastic syndromes (MDS) needs study. We analysed data from 989 MDS subjects classified using the 2016 World Health Organization (WHO) criteria to determine the impact of the new proposal. Our analyses suggested the ICC criteria of MDS-SF3B1 identifies a more homogenous disease entity than the WHO 2016 criteria of myelodysplastic syndromes with ring sideroblasts (MDS-RS). MDS, not otherwise specified with single lineage dysplasia (MDS, NOS-SLD) patients had a better prognosis than MDS, NOS with multilineage dysplasia (MDS, NOS-MLD) patients. MDS with mutated TP53 and MDS/acute myeloid leukaemia with mutated TP53 patients had the briefest survivals. These data support the ICC of MDS, which allows more accurate diagnoses and risk stratification.
引用
收藏
页码:443 / 448
页数:6
相关论文
共 50 条
  • [41] MYELODYSPLASTIC SYNDROMES IN CHILDHOOD - CLASSIFICATION, EPIDEMIOLOGY, AND TREATMENT
    HASLE, H
    LEUKEMIA & LYMPHOMA, 1994, 13 (1-2) : 11 - 26
  • [42] Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS)
    Valent, P
    Wimazal, F
    Schwarzinger, I
    Sperr, WR
    Geissler, K
    WIENER KLINISCHE WOCHENSCHRIFT, 2003, 115 (13-14) : 515 - 536
  • [43] Part 2: Myelodysplastic syndromes - classification systems
    Lorand-Metze, Irene
    Niero-Melo, Ligia
    Buzzini, Renata
    Bernardo, Wanderley Marques
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2018, 40 (03) : 262 - 266
  • [44] FAB CLASSIFICATION OF MYELODYSPLASTIC SYNDROMES - MERITS AND CONTROVERSIES
    VERHOEF, GEG
    PITTALUGA, S
    DEWOLFPEETERS, C
    BOOGAERTS, MA
    ANNALS OF HEMATOLOGY, 1995, 71 (01) : 3 - 11
  • [45] World Health Organization Classification of Myelodysplastic Syndromes
    Czader, Magdalena
    Orazi, Attilio
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (22) : 3149 - 3162
  • [46] Towards an umpteenth prognostic classification in myelodysplastic syndromes?
    Colle, Julien
    HEMATOLOGIE, 2019, 25 (04): : 173 - 173
  • [47] Morphology and classification of the myelodysplastic syndromes and their pathologic variants
    Kouides, PA
    Bennett, JM
    SEMINARS IN HEMATOLOGY, 1996, 33 (02) : 95 - 110
  • [48] Obesity Impact on Outcomes of Myelodysplastic Syndromes
    Al Ali, Najla
    Sallman, David
    Padron, Eric
    Lancet, Jeffery
    List, Alan
    Komrokji, Rami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S262 - S262
  • [49] The incidence and impact of thrombocytopenia in myelodysplastic syndromes
    Kantarjian, Hagop
    Giles, Francis
    List, Alan
    Lyons, Roger
    Sekeres, Mikkael A.
    Pierce, Sherry
    Deuson, Robert
    Leveque, Josvph
    CANCER, 2007, 109 (09) : 1705 - 1714
  • [50] THE IMPACT OF AUTOPHAGY ON THE PROGRESSION OF THE MYELODYSPLASTIC SYNDROMES
    Vilcassim, F. S.
    Banerjee, A.
    Grigoriadis, G.
    LEUKEMIA RESEARCH, 2017, 55 : S127 - S127